Joan Puig de Dou – CEO, Kymos Pharma, Spain
Joan Puig de Dou, CEO of Kymos Pharma, a Spanish analytical CRO, shares his insights in the changing dynamics of the industry and explains how remaining independent in the face…
Reig Jofre (RJ) Group is a family owned Company founded in 1929 and has exhibited strong growth in recent years. RJ is now established as a leading European Development and Manufacturing Company in the Pharmaceutical /Biopharmaceutical markets. The headquarters are located in Barcelona (Spain) and the Group is structured around four main Divisions: Industrial, Biotech, Research/Development & Regulatory and Sales & Marketing.
The Industrial Division provides specialised manufacturing activities through 4 manufacturing sites : RJ Toledo (Spain) has two independent facilities for Penicillin (FDA approved) and Cephalosporin specialties: RJ Barcelona (Spain) specialises in freeze-dried products with a “Center of Excellence in Lyophilisation”, and employs a strong scientific approach based on Quality by Design (QbD) processes, and RJ BIOGLAN –(Malmo, Sweden) Manufacture and R & D for semi-solid/topical products.
The RJ Group manufactures for more than 190 clients/distributors in 55 countries globally
Joan Puig de Dou, CEO of Kymos Pharma, a Spanish analytical CRO, shares his insights in the changing dynamics of the industry and explains how remaining independent in the face…
Luis Campo, CEO of GE Healthcare Spain & Portugal, discusses the opportunities and challenges inherent in the Spanish healthcare system and the ways in which GE is collaborating with authorities…
Luis Maria de Palacio Guerrero, president of the Federacion Empresarial de Farmaceuticos Españoles (FEFE) lifts the lid on plans to reunite the regional affiliates under the national FEFE umbrella. He…
Luis Serrano, president of the Centre for Genomic Regulation (CRG) in Spain, gives an update on the Centre’s recent history and outlines the need for greater understanding of science and…
Carlos Rubió, executive president of Laboratorios Rubió, gives an overview of the company’s early years and his priorities now to make the company a larger player on the international scene.…
Jordi Naval, CEO of Biocat, describes the evolution of the BioRegion of Catalonia as an increasingly relevant biotechnology hub in Spain and Europe. Naval also elaborates on the role of…
Gijs Jochems, general manager of Promega Biotech Iberica, a leading molecular biology solutions provider, speaks about the company’s business transformation to collaborate with diverse areas of the private sector. Jochems…
Joachim Teubner, general manager of Aristo Pharma Iberia, a generics player, highlights the strategy that has helped the company realize rapid growth during a time in which the Spanish generic…
Spain’s biotech scene is on the rise. In 2016 alone, the nation had a total of 651 biotech companies, with a total of 33 commencing operations in 2017. Despite these…
Miguel Valdés, director of Fedifar, the Spanish wholesaler federation, highlights the challenges impacting the local wholesaler network and the unique nature of Spanish wholesaler ecosystem, with the majority of players…
Cédric Ertlé, general director of Laboratoires Expanscience Iberia, talks about his strategy to turn around the affiliate’s dermo cosmetic range in what is a shrinking Spanish market and his goal…
Joël Jean-Mairet, general partner of Ysios Capital, discusses the major trends impacting the venture capital ecosystem in the life sciences sector and the complexity of attracting new investors to the…
See our Cookie Privacy Policy Here